SCHEDULE 13G/A: Millennium Management Amends Stake in Fulgent Genetics, Disclosing 6.5% Beneficial Ownership

Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has filed an amended Schedule 13G, disclosing a 6.5% beneficial ownership stake in Fulgent Genetics, Inc. as of March 31, 2025.

Summary

• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander collectively reported beneficial ownership of 1,969,433 shares of Fulgent Genetics, Inc. Common Stock.
• This represents 6.5% of the outstanding class of securities of Fulgent Genetics, Inc.
• The filing is an Amendment No. 1 to a Schedule 13G, updating a previous beneficial ownership disclosure.
• The reporting persons share both voting and dispositive power over all 1,969,433 beneficially owned shares.
• The securities were not acquired or held for the purpose of changing or influencing control of Fulgent Genetics, Inc., nor in connection with any transaction having such purpose or effect, other than activities solely related to a nomination under Rule 14a-11.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would significantly alter the sentiment towards the company, beyond the general positive signal of institutional investment.

Positives

• Increased institutional ownership by a prominent investment firm like Millennium Management may signal confidence in Fulgent Genetics, Inc.'s long-term prospects.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding Fulgent Genetics, Inc.'s future performance or strategic direction.

Industry Context

This filing is a standard disclosure of beneficial ownership by an institutional investor and does not provide specific insights into broader industry trends or the competitive landscape for the biotechnology or diagnostics sector.

Stakeholder Impact

• Shareholders may view the increased stake by a significant institutional investor as a positive signal of confidence in the company's prospects.

Key Dates

Keywords

Fulgent Genetics, Millennium Management, Schedule 13G/A, Beneficial Ownership, Institutional Investor, Common Stock, FGNT